Integrated Biopharma Inc Q3 FY2025 Earnings Call

Integrated Biopharma Inc (INBP)

Earnings Call FY2025 Q3 Call date: 2025-05-14 Concluded

Quarter scorecard

Revenue

$13.95M

+6.1% YoY

Diluted EPS

$0.02

+100% YoY

Gross margin

11.1%

+1.6 pp YoY

Net income

$611,000

+114.4% YoY

Contract Manufacturing $13.46M

+5.6%

Other Nutraceutical Business $488,000

+22.9%